Responses
Clinical and epidemiological research
Extended report
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
Compose a Response to This Article
Other responses
No responses have been published for this article.